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Background: Moyamoya disease (MMD) is a progressive steno-occlusive vasculopathy that involves large
intracranial arteries accompanied by abnormal collateral vessels. Recently, RNF213 was identified as a susceptibility
gene for MMD and p.Arg4810Lys (rs112735431) is the most common variant in East Asian MMD patients.
Interestingly, many studies have reported that a certain proportion of the general population in Japan, Korea, and
China also has this variant. In this study, we investigated the frequency of this variant and estimated an odds ratio
of MMD using two different Korean populations.
Methods: A total of 1,516 anonymous DNA samples, 799 from an umbilical cord blood bank and 717 from routine
health-checked adults, were genotyped using targeted Sanger sequencing.
Results: The p.Arg4810Lys variant was detected at genotype frequencies of 2.25 % (18/799; 95 % confidence
interval (CI), 1.43-3.53 %) in cord blood samples and 2.65 % (19/717; 95 % CI, 1.70-4.10 %) in adult samples, respectively.
This variant showed a strong association with MMD (P < 0.001), giving an odds ratio of 162.7 (95 % CI, 65.5–403.9) and
137.8 (95 % CI, 55.8–339.9) based on the cord blood and adults samples, respectively.
Conclusions: These results confirm that the RNF213 p.Arg4810Lys variant is not uncommon in the general Korean
population and provide reference data for the association of this variant and MMD.
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Moyamoya disease (MMD; OMIM 607151) is a rare pro-
gressive steno-occlusive vasculopathy that involves intra-
cranial arteries accompanied by abnormal collateral
vessels [1]. The annual incidence of MMD is estimated
to be 0.35–0.94 per 100,000 person-years in Japan [1, 2],
and about one-tenth of that in Europe [3]. In Korea, the
annual incidence steadily increased from 1.7 to 2.3 per
100,000 person-years from 2007 to 2011 [4].
Recently, Kamada et al. identified that RNF213 as a
susceptibility gene for MMD, and p.Arg4810Lys
(rs112735431) as a founder variant common in East Asian
MMD patients [5]. In affected Asian families, Liu et al.* Correspondence: jeannie@snu.ac.kr; changski@skku.edu
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(http://creativecommons.org/publicdomain/zeshowed that the RNF213 p.Arg4810Lys variant segre-
gated with the disease and demonstrated a predomin-
antly autosomal dominant inheritance pattern with
reduced penetrance [6].
Interestingly, the RNF213 p.Arg4810Lys variant has
been found in general populations and the frequency has
been estimated to be 0.9–2.7 % [6–8]. Considering the
frequency (23.1–90.1 %) of the p.Arg4810Lys variant in
MMD, a strong association of this variant and MMD
has been suggested, giving an odds ratio of 112–236
[6–8]. In the Korean population, the frequency of the
p.Arg4810Lys has been estimated to be 2.69–2.72 %
[6, 8]. However, because of the limited numbers of
control subjects used in previous studies, further val-
idation of the frequency in a large Korean population
is necessary. Therefore, we investigated the frequency
of the RNF213 p.Arg4810Lys variant in two Korean
populations.distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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Subjects
A total of 1,516 anonymous DNA samples were included
in this study. Among them, 799 DNAs were obtained
from a public umbilical cord blood bank (Seoul Metro-
politan Public Cord Blood Bank, Korea) and the
remaining 717 DNAs from adult health-examinees were
acquired from a hospital-based biobank. All samples
were collected from unrelated Koreans who provided in-
formed consent, and the study protocol was approved by
the Institutional Review Boards of Seoul National Uni-
versity Boramae Hospital and Samsung Medical Center.Genotyping of RNF213 p.Arg4810K Variant
Exon 60 of RNF213 was amplified using a primer set de-
signed by the authors: RNF213-e60-F, 5’-gctgcatcacag-
gaaatgac-3’ and RNF213-e60-R, 5’-aaggagtgagccgagtttga-
3’. The PCR products were sequenced on an ABI 3730xl
analyzer (Applied Biosystems, Foster City, CA, USA)
using a BigDye Terminator v3.1 Cycle sequencing kit (Ap-
plied Biosystems). Obtained sequence was compared with
the reference sequence for RNF213 (NM_001256071.1).Statistical Analysis
To assess the data quality of RNF213 p.Arg4810Lys vari-
ant, P-values were calculated by an exact test for Hardy-
Weinberg equilibrium [9]. To analyze genotype and
allele frequency data, differences between control and
disease groups were compared by a χ2 or Fisher’s exact
test as appropriate. The calculations were performed
with VassarStats (http://vassarstats.net/), and 95 %
confidence intervals (CI) were calculated for each
value. All P-values were based on two-sided compari-
sons, and P-values < 0.05 were considered to indicate
statistical significance.Table 1 Population frequencies of the RNF213 p.Arg4810Lys variant








Korean (adults) 698 19 0 717
Korean (cord blood) 781 18 0 799
Korean (unknown) 286 8 0 294
Korean (unknown) 217 6 0 223
Japanese (unknown) 1,437 34 3 1,47
Japanese (unknown) 374 9 1 384
Chinese (unknown) 582 5 0 587
Chinese (unknown) 148 2 0 150
Abbreviations: MAF, minor allele frequency; CI, confidence interval
The results from this study are shown in bold
aKorean (adults) vs other studyResults
Genotype distributions of RNF213 p.Arg4810Lys variant
in two different sets were in Hardy-Weinberg equilib-
rium (P = 1.00). Of the 1,516 samples tested by sequence
analysis, 2.44 % (37/1,516; 95 % CI, 1.78–3.35 %) were
heterozygous for the p.Arg4810Lys variant (Table 1). In
the subgroup analysis, the p.Arg4810Lys variant was
detected at genotype frequencies of 2.25 % (18/799;
95 % CI, 1.43–3.53 %) in cord blood samples and 2.65 %
(19/717; 95 % CI, 1.70–4.10 %) in adult samples,
respectively. The genotype frequency of the p.Arg4810Lys
variant allele was similar between groups. No homozygote
was detected in our study. Estimated frequencies of the
variant allele were 1.13 % (95 % CI, 0.72–1.78 %) in cord
blood samples and 1.32 % (95 % CI, 0.85–2.05 %) in adult
samples. In comparison with the data on Korean MMD
patients from a published study (30/38; minor allele
frequency, 39.5 %) [6], the carrier containing the RNF213
p.Arg1480Lys variant showed a strong association with
MMD in the Korean population (P < 0.001), giving an
odds ratio of 162.7 (95 % CI, 65.5–403.9) and 137.8
(95 % CI, 55.8–339.9) based on the cord blood and
adults samples, respectively.Discussion
Early estimates of the genotype and allele frequencies for
RNF213 p.Arg4810Lys have been reported to be 2.69–
2.72 % and 1.35–1.36 % in the Korean population [6, 8],
but so far no large-scale population studies have been
performed. In this study, we confirmed that the geno-
type and allele frequencies of the variant were 2.25–
2.65 % and 1.13–1.32 %, respectively, which are similar
to frequencies in previous reports. The observed fre-
quencies of RNF213 p.Arg1480Lys variant have also
been reported to be similar in proportion to thein Asian countries
ple Carrier frequency % MAF % P-valuea Reference
(95 % CI) (95 % CI)
2.65 (1.70–4.10) 1.32 (0.85–2.05) - This study
2.25 (1.43–3.53) 1.13 (0.72–1.78) 0.76 This study
2.72 (1.38–5.28) 1.36 (0.69–2.66) 1.00 [8]
2.69 (1.24–5.74) 1.35 (0.62–2.91) 1.00 [6]
4 2.51 (1.83–3.44) 1.36 (1.00–1.85) 0.92 [8]
2.60 (1.42–4.72) 1.43 (0.80–2.54) 0.84 [6]
0.85 (0.36–1.98) 0.43 (0.18–1.00) 0.02 [8]
1.33 (0.36–4.73) 0.67 (0.18–2.40) 0.56 [6]
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but the frequencies in the Chinese population are one-
thirds less (Table 1).
In the latest report investigating the prevalence of MMD
in a Korean population cohort, the total number of patients
was 16.1 per 100,000 person-years in 2011 [4], which is a
continually growing trend. There are several explanations
for the high prevalence of MMD. First, the survey is based
on the data from National Health Insurance, which is a
nationwide universal insurance system, thus all inpatients
and outpatients who were diagnosed with MMD were
included. Second, widespread use of non-invasive brain
magnetic resonance imaging might increase the detection
of asymptomatic MMD in adults.
According to data from the Korean Statistical Information
Service (http://kosis.kr/; accessed on 17 December 2014),
the total population was 51.42 million in 2014. Based on
the frequency of carriers in this study, the total number of
carriers was estimated to be 1.25 million. Assuming that
MMD occurs in one of the 300 carriers with the RNF213
p.Arg1480Lys variant [6, 8, 10], the estimated numbers of
Korean patients with MMD attributable to RNF213
p.Arg1480Lys is 4,167. On the basis of the observed
prevalence of 16.1 per 100,000 persons, these numbers are
the minimum estimates, suggesting that this RNF213
p.Arg4810Lys variant is not the single risk factor for MMD.
Other modifying factors, such as other RNF213 rare vari-
ants, another genetic factor, or environmental factors, might
explain the large gap between the prevalence of carrier of
the variant allele and the observed prevalence of MMD.
Conclusions
Our data indicate that the RNF213 p.Arg4810Lys variant
for MMD is not uncommon in the general Korean
population, showing a frequency similar to that of the
Japanese population. To our knowledge, this study repre-
sents the largest Korean cohort to be analyzed for RNF213
p.Arg4810Lys, and this report will provide reference data
for the association of this variant and MMD.
Abbreviations
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